Vaccines Working Party

The European Medicines Agency's (EMA) Vaccines Working Party (VWP) was established by the Committee for Medicinal Products for Human Use (CHMP) to carry out specific tasks related to vaccines.

Also on this topic

• Vaccines Working Party documents

Role

The working party's tasks include:

• preparing, reviewing and updating scientific guidelines and concept papers on non-clinical and clinical development of vaccines against infectious diseases;
• providing product related support upon request from EMA Committees and the Scientific Advice Working Party;
• providing support upon request from other EMA working parties or expert groups;
• European and international co-operation relating to working party activities;
• liaising with interested parties, such as industry, patient organisations and healthcare professional organisations;
• providing trainings and workshops to assessors;

Mandate,rules of procedure and work programme

Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains

Reference Number: EMA/299541/2025

Consolidated 3-year rolling work plan for the Vaccine Working Party (VWP) 2025-2027

Adopted Reference Number: EMA/CHMP/VWP/14129/2025

Composition

The working party is composed of five to nine experts from Member States, selected from the list of European experts and nominated by members of the CHMP. Experts are chosen on the basis of the best and available expertise needed for the working party to deliver its commitments..

The current members are listed below, in alphabetical order of surname. Their declarations of interests are available in the European experts list: 

• European experts

Members

• Mikael Andersson
• Charlotta Bergquist
• Violette Dirix
• Annette Lommel
• Martin Oleksiewicz
• Alicia Pérez González
• Sol Ruiz (Chair)
• Maja Sommerfelt Grønvold
• Eleonora Wijnans (Vice-Chair)